Elena D’Aiuto

Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells

Teresa Troiani, Erika Martinelli, Stefania Napolitano et al. · Clinical Cancer Research · 2013 · 144 citations · Full text

Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines

Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte et al. · Clinical Cancer Research · 2013 · 116 citations

Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion

Veronica Santarlasci, Laura Maggi, Manuela Capone et al. · Immunity · 2012 · 115 citations · Full text

Signal Transduction, T-regulatory Cell, Immunology +6

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells

Erika Martinelli, Teresa Troiani, Elena D’Aiuto et al. · International Journal of Cancer · 2013 · 91 citations · Full text

Multi‐targeted Kinase Inhibitors, Pi3k Inhibitor, Pimasertib‐resistant Human Lung +18

NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells

Elvira Crescenzi, Francesco Pacifico, Alfonso Lavorgna et al. · Oncogene · 2011 · 69 citations

Cancer Research, Cytokine, Cancer Immunosurveillance +12